These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4281242)

  • 41. Combined live measles-mumps virus vaccine.
    Weibel RE; Villarejos VM; Hernández G; Stokes J; Buynak EB; Hilleman MR
    Arch Dis Child; 1973 Jul; 48(7):532-6. PubMed ID: 4719108
    [No Abstract]   [Full Text] [Related]  

  • 42. Trial of a reduced dose of measles vaccine in Nigerian children.
    Wallace RB; Landrigan PJ; Smith EA; Pifer J; Teller B; Foster SO
    Bull World Health Organ; 1976; 53(4):361-4. PubMed ID: 1086728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined live measles, mumps, and rubella virus vaccines.
    Buynak EB; Weibel RE; Whitman JE; Stokes J; Hilleman MR
    JAMA; 1969 Mar; 207(12):2259-62. PubMed ID: 5818433
    [No Abstract]   [Full Text] [Related]  

  • 44. Effectiveness of measles vaccine given simultaneously with DTP.
    Marshall R; Habicht JP; Landrigan PJ; Foege WH; Delgado H
    J Trop Pediatr Environ Child Health; 1974 Jun; 20(3):126-9. PubMed ID: 4612169
    [No Abstract]   [Full Text] [Related]  

  • 45. [Persistence of immunity to attenuated measles live vaccine. VI. Observation on the results of revaccination with different vaccines via varied routes].
    Zhonghua Yi Xue Za Zhi; 1983 Sep; 63(9):541-5. PubMed ID: 6418355
    [No Abstract]   [Full Text] [Related]  

  • 46. Persistence of measles antibody in the absence of circulating natural virus five years after immunization of an isolated virgin population with Edmonston B vaccine.
    Brown P; Gajdusek DC; Tsai T
    Am J Epidemiol; 1969 Dec; 90(6):514-8. PubMed ID: 5362859
    [No Abstract]   [Full Text] [Related]  

  • 47. Measles in children previously vaccinated against measles.
    Lerman SJ; Gold E
    JAMA; 1971 May; 216(8):1311-4. PubMed ID: 4102807
    [No Abstract]   [Full Text] [Related]  

  • 48. [The strength of postvaccinal measles immunity in schoolchildren].
    Smorodinova IP; Miroshnikova NK; Sobolevskaia AA
    Tr Inst Im Pastera; 1985; 62():46-50. PubMed ID: 2954275
    [No Abstract]   [Full Text] [Related]  

  • 49. Measles immune-status surveys in Manitoba.
    Sekla L; Stackiw W; Drewniak M
    Can J Public Health; 1979; 70(6):415-7. PubMed ID: 534989
    [No Abstract]   [Full Text] [Related]  

  • 50. Evaluation of measles-rubella vaccination for mothers in early puerperal phase.
    Hisano M; Kato T; Inoue E; Sago H; Yamaguchi K
    Vaccine; 2016 Feb; 34(9):1208-14. PubMed ID: 26801065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Measles: old vaccines, new vaccines.
    Griffin DE; Pan CH
    Curr Top Microbiol Immunol; 2009; 330():191-212. PubMed ID: 19203111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Measles immunization with further attenuated heat-stable measles vaccine using five different methods of administration.
    Kok PW; Kenya PR; Ensering H
    Trans R Soc Trop Med Hyg; 1983; 77(2):171-6. PubMed ID: 6868097
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Simultaneous administration of smallpox, measles, yellow fever, and diphtheria-pertussis-tetanus antigens to Nigerian children.
    Ruben FL; Smith EA; Foster SO; Casey HL; Pifer JM; Wallace RB; Atta AI; Jones WL; Arnold RB; Teller BE; Shaikh ZQ; Lourie B; Eddins DL; Doko SM; Foege WH
    Bull World Health Organ; 1973; 48(2):175-81. PubMed ID: 4541683
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evidence for reinstatement of infants 12 to 14 months of age into routine measles immunization programs.
    Wilkins J; Wehrle PF
    Am J Dis Child; 1978 Feb; 132(2):164-6. PubMed ID: 626182
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Transplacental measles immunity in infants in the 1st year of life].
    Bystriakova LV; Zaĭtseva RV; Kolobova LV; Pushkareva EA; Smorodinova IP
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Oct; (10):50-2. PubMed ID: 1839342
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Serologic indices of measles immunity in children exposed to measles].
    Tikhonova NT; Khrometskaia TM; Ignat'eva GV; Gerasimova AG; Livanova LV
    Vopr Virusol; 1974; 19(0):357-63. PubMed ID: 4837951
    [No Abstract]   [Full Text] [Related]  

  • 57. Measles immunity in children vaccinated before one year of age.
    Schluederberg A; Lamm SH; Landrigan PJ; Black FL
    Am J Epidemiol; 1973 Jun; 97(6):402-9. PubMed ID: 4713935
    [No Abstract]   [Full Text] [Related]  

  • 58. Enteric administration of a live attenuated measles vaccine does not induce protective immunity in a macaque model.
    Stittelaar KJ; de Swart RL; Vos HW; van Amerongen G; Agafonov AP; Nechaeva EA; Osterhaus AD
    Vaccine; 2002 Jul; 20(23-24):2906-12. PubMed ID: 12126901
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Determination of measles immunity after a mass immunization campaign.
    Levitt LP; Case GE; Neil JS; Casey HL; Adler P; Ferreri S; Witte JJ
    Public Health Rep (1896); 1970 Mar; 85(3):261-5. PubMed ID: 4984891
    [No Abstract]   [Full Text] [Related]  

  • 60. Studies on further attenuated live measles vaccine. VIII. Estimated duration of immunity after vaccination without natural infection.
    Ueda S; Okuno Y; Sakamoto Y; Sangkawibha N; Tuchinda P
    Biken J; 1974 Mar; 17(1):11-20. PubMed ID: 4854462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.